menu
    • menu

    Company profile for Byondis

    NEW Drugs in Dev: 7
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Byondis we put cutting-edge science, ability to innovate and talented people into action to create precision medicines which provide the best possible outcomes for patients with relentless cancers and auto-immune diseases. Byondis focuses on development of innovative medicines, including antibody-drug conjugates, in two key therapeutic areas: oncology and autoimmune diseases. We provide a fair, human, open and inspiring ...
    At Byondis we put cutting-edge science, ability to innovate and talented people into action to create precision medicines which provide the best possible outcomes for patients with relentless cancers and auto-immune diseases. Byondis focuses on development of innovative medicines, including antibody-drug conjugates, in two key therapeutic areas: oncology and autoimmune diseases. We provide a fair, human, open and inspiring working environment, with room for ambition, entrepreneurship and new initiatives - leading to new medicines with the potential to transform patients’ lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ByondisNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Microweg 22 P.O. Box 6570 6503 GB Nijmegen
    Telephone
    Telephone
    +31 (0)24 679 5100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.byondis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/byondis/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Byondis To Showcase Novel ADC Technology At ASCR Meeting 2026
    Byondis To Showcase Novel ADC Technology At ASCR Meeting 2026

    17 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7184561

    FIRSTWORD PHARMA
    17 Apr 2026
    Share Share
    Byondis Names Christoph Korpus as Chief Executive Officer
    Byondis Names Christoph Korpus as Chief Executive Officer

    09 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260409851749/en/ADDING-MULTIMEDIA-Byondis-Appoints-Christoph-Korpus-PhD-MBA-as-Chief-Executive-Officer

    BUSINESSWIRE
    09 Apr 2026
    Share Share
    Byondis Doses First Patient in BYON4228 Phase 1 Trial
    Byondis Doses First Patient in BYON4228 Phase 1 Trial

    03 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250603807653/en/Byondis-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-Novel-SIRP-Directed-Monoclonal-Antibody-BYON4228-in-Patients-With-Advanced-or-Metastatic-Solid-Tumors

    BUSINESSWIRE
    03 Jun 2025
    Share Share
    Byondis Appoints Christoph Korpus as Chief Business Officer
    Byondis Appoints Christoph Korpus as Chief Business Officer

    24 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250324077182/en/Byondis-Appoints-Christoph-Korpus-PhD-MBA-as-Chief-Business-Officer

    BUSINESSWIRE
    24 Mar 2025
    Share Share
    Byondis nomme Louis Denis, M.D., au poste de Chief Medical Officer
    Byondis nomme Louis Denis, M.D., au poste de Chief Medical Officer

    19 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241118767330/fr

    BUSINESSWIRE
    19 Nov 2024
    Share Share
    Byondis Appoints Louis Denis, M.D., as Chief Medical Officer
    Byondis Appoints Louis Denis, M.D., as Chief Medical Officer

    19 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241118495587/en

    BUSINESSWIRE
    19 Nov 2024
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Byondis and get a quotation

    Byondis is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find Duocarmazine bulk with DMF offered by Byondis

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search